The advance in genomic technology may help with the fight of cancer. Even though scientist and doctors don’t know about the patient’s acceptance of personalized medicine and wide spread of genetic testing. The current study of genomic medicine leads to un-expected advances in oncology due to the extreme advances in technology.
Doctors and Scientist conducted a study on volunteers at a facility called Danna-Farber Cancer Institute (DFCI). There were also were acceptance requirements in order to receive treatment through the experiment. The requirements were to be at least 18 years of age or older, English speaking, less than two visits to (DFCI) between 01/01/08 and 03/1/11.
Categorizing the patients was of extreme importance because of the different types of cancer ...view middle of the document...
Most of the patients were unaware of the meaning of the experiment.
At the end of the study Scientist would ask the volunteers a series of questions about the study. Only a couple participants said that they understood the definition of personalized medicine the other half said that they have never heard of the term. During the process of the experiment some volunteers walked away and did not complete the experiment.
Volunteers that took well to the treatment found that it came with some rewards in good health improvement. Those that did not finish the experiment came to fill little or no improvement.
Limitations to the experiment were very profound and were very hard to get more volunteers to come do the study. Participants did not know anything about the experiment and some could have thought that the whole experiment could have been a fluke. Scientist would have thoughts that more participants would come only if they were desperate enough to show.
End results were that scientist has found that personalized medicine was not a term well known to some patients. Scientist believe that more work is needed so that clinicians and researcher’s with a more broad of understanding of personalized medicine. With-out doing so there may be failure to optimize the delivery of cutting-edge genetically guided cancer care.
Cancer is very deadly and I do believe that everyone that has any type of tumors should get help immediately. Before trying an experiment I do believe that you should also some research about the experiment and ask plenty of questions about the producers. Ask if there are any effects after the process is done.
Journal of Oncology Practice and the American Society of Clinical Oncology
Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts General Hospital, Boston, MA.